On the Friday, October 21st 2011 broadcast Dr. Richard Just chats with Jeff Hall, Ph.D., Vice President, Genoptix, 'a world-class specialized laboratory service dedicated to partnering with community hematologist/oncologists to more effectively manage patient care.' This will be a discussion of the clinical significance of emerging biomarkers in cancer care.
Dr. Just explores the relevance of biomarkers to the growing interest in personalized medicine and individualized cancer care. Dr. Hall provides both history and context, and at one point opines that 'the issue is the tissue', and much more.
This is a lively discussion between two engaged professionals in this exciting new domain for diagnostic medicine.
Dr. Hall is the Vice President Cell Biology at Genoptix.